by Erin | Jul 28, 2025 | Blog
Specialty doctors are concerned about the harmful impacts of prescription drug affordability boards, a white paper commissioned by the Value of Care Coalition recently found. The survey asked endocrinologists, rheumatologists and HIV specialists for their opinions on...
by Erin | Jul 16, 2025 | Blog
While some states continue to struggle with the operations of Prescription Drug Affordability Boards (PDABs), others are saying “no” to upper payment limits altogether. This year, the governors of Virginia and Nevada vetoed legislation that would have either...
